Mouse Study Shows Immune Signal Blockade Reverses Aging Markers

Stanford researchers found blocking one immune signal in aging mice reversed multiple aging markers, including muscle loss and heart dysfunction, with liver tissue playing a key role in the process.

Stanford University researchers published findings in *Science* (2026) showing that blocking the EP2 receptor on tissue-resident macrophages reversed aging markers in older mice. The intervention restored 59 of 71 proteins linked to aging toward youthful levels, improving memory, muscle mass, and heart function. Liver tissue emerged as a critical site where aging-related changes in blood chemistry occurred, driven by high density of these immune cells. Reanalysis of existing human liver and heart tissue data revealed similar patterns—reduced tissue-resident macrophages and increased EP2 expression—but without the neutrophil buildup seen in mice. While the study suggests a potential pathway for human anti-aging therapies, no drugs selectively target EP2 for human use exist, and the findings remain confined to mouse models despite human tissue reanalysis.

This work identifies a specific immune mechanism that could theoretically reduce healthcare costs for age-related conditions if translated to humans. However, human therapeutic applications remain speculative due to the lack of causal evidence in people and the need for safety validation—blocking EP2 in humans would risk disrupting essential immune functions. The next critical step is confirming whether EP2 blockade safely reverses aging in humans without compromising immune health, a hurdle the study explicitly states requires further investigation. The findings do not yet establish human aging mechanisms or therapeutic viability.

Source: ScienceAlert